How a Psychopharmacology Clinical Trial Site in the Seattle Area Managed Clinical Trials and Patient Care During the COVID-19 Pandemic

•As the COVID 19 pandemic developed rapidly in early March 2020 in the greater Seattle area, our clinical trial site faced a number of clinical and ethical dilemmas in how to safely maintain services to our high-risk research patient population including geriatric patients, staff, and visitors.•We have developed evolving screening procedures for symptoms related to COVID 19 and restructured our center to remain operational to see our clinical trial patients. Patients and staff have been able to adapt.•We have been able to maintain clinical trial research during the beginning of the COVID 19 pandemic but further follow up is required to fully assess the effects of the pandemic to clinical trial sites and participants.